Cite
HARVARD Citation
Mu, X. et al. (2018). Comparison of pulsed actinomycin D and 5‐day actinomycin D as first‐line chemotherapy for low‐risk gestational trophoblastic neoplasia. International journal of gynaecology and obstetrics. 143 (2), pp. 225-231. [Online].